![]() Immunovia Immunovia engages in the development of a technology platform based on antibody microarray analysis. | bioAffinity Technologies bioAffinity Technologies is a company focusing on the diagnosis of early-stage cancer, diseases of the lung, and targeted cancer treatment. | ||
Founding Date | Founding Date 2014 | Founding Date 2007 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ | Locations Lund, SE HQ Lund, SE Marlborough, US | Locations San Antonio, US HQ San Antonio, US |
Employees | Employees 4172% increase | Employees 9 | Employees 11 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.2 m | Valuation ($) 21.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr685k (FY, 2025) | Revenue (est.) $6.2m (FY, 2025) |
Net income | Net income N/A | Net income (kr145.9m) (FY, 2025) | Net income ($14.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 507.6m | Total funding raised $ 5.2m | Total funding raised $ 4.2m |

Immunovia engages in the development of a technology platform based on antibody microarray analysis.
View companybioAffinity Technologies is a company focusing on the diagnosis of early-stage cancer, diseases of the lung, and targeted cancer treatment.
View company